The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1195
November 8, 2004
View Complete Issue         Table of Contents 2019 
Systemic Reactions to Imiquimod (Aldara)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Systemic Reactions to Imiquimod (Aldara)
November 8, 2004 (Issue: 1195)
Our May 24, 2004 article on use of the immune response modulator imiquimod (Aldara) for treatment of actinic keratoses stated that no systemic effects have been detected. A physician reader objected, stating that he had developed fatigue while using...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Systemic Reactions to Imiquimod (Aldara)
Article code: 1195c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.